Cellmid Limited
AU· latest recorded location
Cellmid Limited is named on 5 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 5
- Published applications
- 4
- Inventors
- 20
- Granted in 2026 so far
- 0
- Most recent grant
- 17 Mar 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 2 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
By publication year.
Technology areas
Share of 9 documents
Recent patents
- Midkine antibody17 Mar 2020US 10,590,192 B2
- Antibody recognizing N-domain of midkine18 Apr 2017US 9,624,294 B2
- Method to reduce loss of cardiac function following ischemia/reperfusion5 May 2015US 9,023,799 B2
- Anti-midkine antibody for preventing post-laparotomy adhesions17 Jul 2012US 8,221,758 B2
- Method for treatment or prevention of disease associated with functional disorder of regulatory T cell6 Mar 2012US 8,128,934 B2
- Improved midkine antibody24 Aug 2017US 2017/0240628 A1
- Antibody recognizing n-domain of midkine19 Jun 2014US 2014/0170144 A1
- Method for Treatment or Prevention of Disease Associated Wtih Functional Disorder of Regulatory T Cell15 Apr 2010US 2010/0092488 A1
- Preventive for adhesion following abdominal surgery6 Jul 2006US 2006/0148738 A1
Most cited
By later US patents